Indutrade has signed an agreement to acquire all of the shares in Rubin Medical AB, Sweden, with annual sales of approximately SEK 100 million. The company will be part of Indutrade’s Industrial Components business area.
Rubin Medical is a supplier of medical technology products with a focus on diabetes therapy in Scandinavia. The main products are insulin pumps, infusion sets and other devices. Ina Nissen and Milael Cederhag founded Rubin Medical in 2003 and the company has since then enjoyed a remarkable growth.
”Since our first acquisition in medical technology in 2008 we have grown from SEK 60 million to SEK 330 million in this segment”, says Johnny Alvarsson, President and CEO of Indutrade.
Lars Weibull AB acted as advisor on the seller´s side in the transaction.